GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic AS (CHIX:BAVAc) » Definitions » Float Percentage Of Total Shares Outstanding

Bavarian Nordic AS (CHIX:BAVAC) Float Percentage Of Total Shares Outstanding : 0.00% (As of Dec. 12, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Bavarian Nordic AS Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bavarian Nordic AS's float shares is 0.00 Mil. Bavarian Nordic AS's total shares outstanding is 78.57 Mil. Bavarian Nordic AS's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bavarian Nordic AS's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bavarian Nordic AS's Institutional Ownership is 20.00%.


Bavarian Nordic AS Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Bavarian Nordic AS's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/78.57
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bavarian Nordic AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic AS (CHIX:BAVAc) » Definitions » Float Percentage Of Total Shares Outstanding
Address
Philip Heymans Alle 3, Hellerup, DNK, DK-2900
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.

Bavarian Nordic AS Headlines

No Headlines